Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease

Objectives: In a prospective 4-year study, we evaluated the progression of motor and non-motor symptoms in Parkinson's disease (PD) patients with Asian-specific LRRK2 risk variants and non-carriers.Methods: A total of 202 patients with PD, including 133 risk variant carriers and 69 non-carriers...

Full description

Bibliographic Details
Main Authors: Xiao Deng, Bin Xiao, Hui-Hua Li, Ebonne Ng, Yew-Long Lo, Eng-King Tan, Kumar M. Prakash
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.01379/full
_version_ 1828382527443697664
author Xiao Deng
Bin Xiao
Hui-Hua Li
Ebonne Ng
Yew-Long Lo
Yew-Long Lo
Eng-King Tan
Eng-King Tan
Kumar M. Prakash
Kumar M. Prakash
author_facet Xiao Deng
Bin Xiao
Hui-Hua Li
Ebonne Ng
Yew-Long Lo
Yew-Long Lo
Eng-King Tan
Eng-King Tan
Kumar M. Prakash
Kumar M. Prakash
author_sort Xiao Deng
collection DOAJ
description Objectives: In a prospective 4-year study, we evaluated the progression of motor and non-motor symptoms in Parkinson's disease (PD) patients with Asian-specific LRRK2 risk variants and non-carriers.Methods: A total of 202 patients with PD, including 133 risk variant carriers and 69 non-carriers, were followed up and evaluated using the Modified Hoehn and Yahr staging scale, Unified Parkinson's Disease Rating Scale part III, Non-motor Symptom Scale, Parkinson's disease Questionnaire-39 item version. Means of generalized estimating equation model was performed to compare the differences from baseline between LRRK2 risk variant carriers and non-carriers.Results: Our longitudinal analysis revealed that risk variant carriers exhibited greater progression than non-carriers after 4 years based on the modified Hoehn and Yahr staging scale (risk variants carriers, 0.65; non-carriers, 0.06; P = 0.041). Meanwhile, Unified Parkinson's Disease Rating Scale gait and posture score in risk variant carriers also showed greater increase than that in non-carriers, although the difference was not statistically significant. Non-carriers experienced a transient improvement in non-motor symptoms at the early stage of PD, as scores at visit two significantly reduced compared to baseline in Non-motor Symptom Scale domain 3 (mood/apathy), Parkinson's disease Questionnaire-39 item version domain 3 (emotional well-being), and frequency of NMS in non-carriers but not in risk variants carriers.Conclusions: PD gene risk variant carriers were more likely to progress faster in their motor severity than non-carriers. There were transient differences in certain non-motor symptoms and quality of life in carriers. However, more studies are warranted to assess the association of PD risk variants and progression of non-motor symptoms.
first_indexed 2024-12-10T04:33:21Z
format Article
id doaj.art-c46f81165a994dafba4e7c0d5f4d7af7
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-10T04:33:21Z
publishDate 2020-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-c46f81165a994dafba4e7c0d5f4d7af72022-12-22T02:02:04ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-01-011010.3389/fneur.2019.01379473559Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's DiseaseXiao Deng0Bin Xiao1Hui-Hua Li2Ebonne Ng3Yew-Long Lo4Yew-Long Lo5Eng-King Tan6Eng-King Tan7Kumar M. Prakash8Kumar M. Prakash9Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore, SingaporeDepartment of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore, SingaporeHealth Services Research Unit, Singapore General Hospital, Singapore, SingaporeDepartment of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore, SingaporeDepartment of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore, SingaporeSignature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School, Singapore, SingaporeDepartment of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore, SingaporeSignature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School, Singapore, SingaporeDepartment of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore, SingaporeSignature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School, Singapore, SingaporeObjectives: In a prospective 4-year study, we evaluated the progression of motor and non-motor symptoms in Parkinson's disease (PD) patients with Asian-specific LRRK2 risk variants and non-carriers.Methods: A total of 202 patients with PD, including 133 risk variant carriers and 69 non-carriers, were followed up and evaluated using the Modified Hoehn and Yahr staging scale, Unified Parkinson's Disease Rating Scale part III, Non-motor Symptom Scale, Parkinson's disease Questionnaire-39 item version. Means of generalized estimating equation model was performed to compare the differences from baseline between LRRK2 risk variant carriers and non-carriers.Results: Our longitudinal analysis revealed that risk variant carriers exhibited greater progression than non-carriers after 4 years based on the modified Hoehn and Yahr staging scale (risk variants carriers, 0.65; non-carriers, 0.06; P = 0.041). Meanwhile, Unified Parkinson's Disease Rating Scale gait and posture score in risk variant carriers also showed greater increase than that in non-carriers, although the difference was not statistically significant. Non-carriers experienced a transient improvement in non-motor symptoms at the early stage of PD, as scores at visit two significantly reduced compared to baseline in Non-motor Symptom Scale domain 3 (mood/apathy), Parkinson's disease Questionnaire-39 item version domain 3 (emotional well-being), and frequency of NMS in non-carriers but not in risk variants carriers.Conclusions: PD gene risk variant carriers were more likely to progress faster in their motor severity than non-carriers. There were transient differences in certain non-motor symptoms and quality of life in carriers. However, more studies are warranted to assess the association of PD risk variants and progression of non-motor symptoms.https://www.frontiersin.org/article/10.3389/fneur.2019.01379/fullParkinson's diseaseprogressionLRRK2motornon-motor
spellingShingle Xiao Deng
Bin Xiao
Hui-Hua Li
Ebonne Ng
Yew-Long Lo
Yew-Long Lo
Eng-King Tan
Eng-King Tan
Kumar M. Prakash
Kumar M. Prakash
Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease
Frontiers in Neurology
Parkinson's disease
progression
LRRK2
motor
non-motor
title Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease
title_full Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease
title_fullStr Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease
title_full_unstemmed Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease
title_short Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease
title_sort four year longitudinal study of motor and non motor symptoms in lrrk2 related parkinson s disease
topic Parkinson's disease
progression
LRRK2
motor
non-motor
url https://www.frontiersin.org/article/10.3389/fneur.2019.01379/full
work_keys_str_mv AT xiaodeng fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease
AT binxiao fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease
AT huihuali fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease
AT ebonneng fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease
AT yewlonglo fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease
AT yewlonglo fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease
AT engkingtan fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease
AT engkingtan fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease
AT kumarmprakash fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease
AT kumarmprakash fouryearlongitudinalstudyofmotorandnonmotorsymptomsinlrrk2relatedparkinsonsdisease